Reaction
Connective Tissue Disorder reporting signals
As of the last recalculation, Connective Tissue Disorder appears in 1,405 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is CIPROFOLXACIN (PRR 22.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciprofolxacin | 100 | 22.2 | 22.2 |
| Ciprofloxacin Tablets | 100 | 22.2 | 22.2 |
| Ciprofloxacin Hydrochloride | 124 | 20.6 | 20.6 |
| Ciprofloxacin | 117 | 20.5 | 20.5 |
| Sulfur | 7 | 12.4 | 12.4 |
| Ciprofloxacin Hydrochloride And Hydrocortisone | 17 | 12.2 | 12.3 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 6 | 10.4 | 10.4 |
| Liothyronine Sodium | 6 | 10.2 | 10.3 |
| Epoprostenol | 8 | 9.1 | 9.1 |
| Sodium Oxybate | 38 | 8.7 | 8.8 |
| Asfotase Alfa | 5 | 7.4 | 7.4 |
| Selexipag | 12 | 6.9 | 6.9 |
| Ambrisentan | 39 | 4.7 | 4.7 |
| Lifitegrast | 4 | 3.6 | 3.6 |
| Galcanezumab-Gnlm | 4 | 1.9 | 1.9 |
| Etonogestrel | 6 | 1.9 | 1.9 |
| Salicylic Acid | 4 | 1.1 | 1.1 |